Human HDAC8 is a class I HDAC and has been identified in a variety of human cancer tissues. Cayman’s HDAC8 Inhibitor Screening Assay provides a convenient fluorescence-based method for screening HDAC8 inhibitors. The procedure requires only two easy steps, both performed in the same microplate. The fluorescent reaction product is analyzed with an excitation wavelength between 350-360 nm and an emission wavelength between 450-465 nm. Sufficient HDAC8 is provided for 100 tests.
